Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Melatonin Acts as Antioxidant and Improves Sleep in MS Patients.
[A review of multiple sclerosis (1). Presentation of a case.]
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Fingolimod for relapsing-remitting multiple sclerosis.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Plasmacytoid dendritic cells and autoimmune inflammation.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Open Ring Sign Diagnostic of Multiple Sclerosis in the Emergency Department.
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Subacute CNS demyelination after treatment with nivolumab for melanoma.
Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration.
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Validation of an Arabic version of Fatigue Severity Scale.
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
Guillain-Barre Syndrome After Robotically Assisted Laparoscopic Prostatectomy: First Case Report.
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Oligodendrocyte plasticity with an intact cell body in vitro.
Myelin proteomics: the past, the unexpected and the future.
Dock3 protects myelin in the cuprizone model for demyelination.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.

Pages